Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Clinical trial NCT02064439 · COMPLETED

Trial details

NCT number: NCT02064439
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Embolism Thromboembolism Thrombosis Venous Thrombosis Venous Thromboembolism

Start date: 2014-03-05
Primary completion: 2016-09-22
Enrollment: 3365

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.